---
title: Impacts of ICH GCP E6 (R3) Webinar
description: Learn how to future-proof your clinical quality processes and navigate the new ICH GCP E6 (R3) guidelines in a digital-first regulatory landscape.
image: https://hallorancg.com/hubfs/Landing%20Pages/Events/2025%20Scope/hgc-event-scope-2025-hero-5-1.webp
---

![](https://hallorancg.com/hs-fs/hubfs/Landing%20Pages/Events/2025%20Scope/hgc-event-scope-2025-hero-5-1.webp?width=300&name=hgc-event-scope-2025-hero-5-1.webp)

[Sheila Gwizdak](https://hallorancg.com/insights/author/sheila-gwizdak)Apr 7, 2025 9:34:32 AM1 min read

# Impacts of ICH GCP E6 (R3) Webinar

Join Halloran Consulting Group for a compelling discussion on how to future-proof your clinical quality processes and navigate global regulatory expectations as you transition to ICH GCP E6 (R3)  compliance in a rapidly evolving digital environment.

[Watch Now](https://event.on24.com/wcc/r/4891702/D204A50297DE5EF4B7F20F41364FE412)

The ICH GCP E6 (R3) guideline represents a transformative global shift in Good Clinical Practice (GCP), aligning with the evolving expectations of regulatory agencies such as the FDA, EMA, and PMDA. With a strong emphasis on risk-based quality management (RBQM), data integrity, and technology-driven oversight, this update challenges sponsors, CROs, and sites to redefine their approach to compliance, quality, and clinical trial execution in an increasingly digital-first environment.

 

In this insight-driven webinar, our industry experts will demystify the key changes introduced in GCP E6 (R3) and examine how regulatory authorities worldwide are adapting to digital transformation in clinical trial oversight. 

 

Viewers will gain global perspectives and actionable strategies on:

- Key updates in GCP E6 (R3) and their implications for sponsors, CROs, and sites
- The evolving role of risk-based quality management (RBQM) in clinical trial execution and regulatory expectations
- Harnessing AI, automation, and digital tools to optimize compliance, oversight and operational efficiency
- Best practices for ensuring data integrity and risk-based monitoring in a globally regulated digital environment
- Strategic steps to implement digital-first quality management approaches that comply with international regulatory requirements

[Download our key takeaways](https://hallorancg.com/hubfs/Halloran%20Webinar%20-%20ICH%20GCP%20E6(R3)%20-%20Takeaways%20-%204.1.2025.pdf)

 

[Sheila Gwizdak

](https://hallorancg.com/insights/author/sheila-gwizdak)

## RELATED ARTICLES

[

Lyn AgostinelliMar 2, 2026 3:51:46 PM3 min read

### Success is in Leveraging People and Process - Insights from SCOPE

Start Reading 

](https://hallorancg.com/insights/leveraging-people-and-process-for-optimal-results)[

Carolina Ahrendt, MBA, PMPJan 26, 2026 8:15:02 AM7 min read

### Utilize the New FDA Marketing Application Filing Checklist to Prevent RTFs

Start Reading 

](https://hallorancg.com/insights/utilize-the-new-fda-marketing-application-filing-checklist-to-prevent-rtfs)[

Nicole GalloJan 8, 2026 1:15:01 PM4 min read

### 2026 Regulatory Momentum at the U.S. FDA

Start Reading 

](https://hallorancg.com/insights/2026-regulatory-momentum-at-the-u.s.-fda)

<https://hallorancg.com/insights/impacts-of-ich-gcp-e6-r3-webinar#>

```json
{
  "@context" : "https://schema.org",
  "@type" : "Organization",
  "address" : {
    "@type" : "PostalAddress",
    "addressCountry" : "",
    "addressLocality" : "Cambridge",
    "addressRegion" : "MA",
    "postalCode" : "02142",
    "streetAddress" : "245 Main Street"
  },
  "knowsLanguage" : "en",
  "logo" : {
    "@type" : "ImageObject",
    "url" : "https://9483922.fs1.hubspotusercontent-na1.net/hubfs/9483922/Orange%20Tree%20Blue%20Text.png"
  },
  "name" : "Halloran Consulting Group, a PLG Company",
  "url" : "https://hallorancg.com/insights/impacts-of-ich-gcp-e6-r3-webinar"
}
```

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "abstract" : "Learn how to future-proof your clinical quality processes and navigate the new ICH GCP E6 (R3) guidelines in a digital-first regulatory landscape.",
  "author" : {
    "@type" : "Person",
    "name" : "Sheila Gwizdak"
  },
  "dateModified" : "April 9, 2025 1 PM",
  "datePublished" : "April 7, 2025 1 PM",
  "headline" : "Impacts of ICH GCP E6 (R3) Webinar",
  "image" : "https://9483922.fs1.hubspotusercontent-na1.net/hubfs/9483922/Landing%20Pages/Events/2025%20Scope/hgc-event-scope-2025-hero-5-1.webp",
  "inLanguage" : "en",
  "keywords" : "[Strategic Advising, Webinars, Regulatory Affairs and Operations]",
  "mainEntityOfPage" : {
    "@type" : "WebPage"
  },
  "name" : "Impacts of ICH GCP E6 (R3) Webinar",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://9483922.fs1.hubspotusercontent-na1.net/hubfs/9483922/Orange%20Tree%20Blue%20Text.png"
    },
    "name" : "Halloran Consulting Group, a PLG Company"
  },
  "text" : "Join Halloran Consulting Group for a compelling discussion on how to future-proof your clinical quality processes and navigate global regulatory expectations as you transition to ICH GCP E6 (R3) compliance in a rapidly evolving digital environment. Watch Now The ICH GCP E6 (R3) guideline represents a transformative global shift in Good Clinical Practice (GCP), aligning with the evolving expectations of regulatory agencies such as the FDA, EMA, and PMDA. With a strong emphasis on risk-based quality management (RBQM), data integrity, and technology-driven oversight, this update challenges sponsors, CROs, and sites to redefine their approach to compliance, quality, and clinical trial execution in an increasingly digital-first environment. In this insight-driven webinar, our industry experts will demystify the key changes introduced in GCP E6 (R3) and examine how regulatory authorities worldwide are adapting to digital transformation in clinical trial oversight. Viewers will gain global perspectives and actionable strategies on: Key updates in GCP E6 (R3) and their implications for sponsors, CROs, and sites The evolving role of risk-based quality management (RBQM) in clinical trial execution and regulatory expectations Harnessing AI, automation, and digital tools to optimize compliance, oversight and operational efficiency Best practices for ensuring data integrity and risk-based monitoring in a globally regulated digital environment Strategic steps to implement digital-first quality management approaches that comply with international regulatory requirements Download our key takeaways",
  "url" : "https://hallorancg.com/insights/impacts-of-ich-gcp-e6-r3-webinar",
  "wordCount" : "744"
}
```

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Sheila Gwizdak",
    "url" : "https://hallorancg.com/insights/author/sheila-gwizdak"
  },
  "dateModified" : "2025-04-09T13:11:48.904Z",
  "datePublished" : "2025-04-07T13:34:32.000Z",
  "headline" : "Impacts of ICH GCP E6 (R3) Webinar",
  "image" : [ "https://hallorancg.com/hubfs/Landing%20Pages/Events/2025%20Scope/hgc-event-scope-2025-hero-5-1.webp" ],
  "mainEntityOfPage" : {
    "@id" : "https://hallorancg.com/insights/impacts-of-ich-gcp-e6-r3-webinar",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://hallorancg.com/hubfs/Orange%20Tree%20Blue%20Text.png"
    },
    "name" : "Halloran Consulting Group"
  }
}
```